Should baseline-dependent cut-offs really be used to define disease improvement in juvenile idiopathic arthritis? And few other considerations
Rheumatology (Oxford)
.
2017 Jan;56(1):165-167.
doi: 10.1093/rheumatology/kew361.
Epub 2016 Oct 22.
Authors
Olivier Collignon
1
2
,
Richard Veselý
3
Affiliations
1
Human Medicines Evaluation Division - Biostatistics and Methodology Support, European Medicines Agency, London, UK olivier.collignon@ema.europa.eu.
2
Competence Center in Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg.
3
Human Medicines Evaluation Division - Rheumatology, Respiratory, Gastroenterology & Immunology, European Medicines Agency, London, UK.
PMID:
28028162
DOI:
10.1093/rheumatology/kew361
No abstract available
Publication types
Letter
Comment
MeSH terms
Arthritis, Juvenile*
Humans
Severity of Illness Index*